|
| |
Image Results
Loading...
Loading...
TAMOXIFEN Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
Tamoxifen - Wikipedia, the free encyclopedia
Tamoxifen is an antagonist of the estrogen receptor in breast tissue. It has been the standard endocrine (anti-estrogen) therapy for hormone-positive early ...
http://en.wikipedia.org/wiki/Tamoxifen...
|
Tamoxifen: MedlinePlus Drug Information
Features information about dosage, usage, warnings, and side effects.
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682414.htm...
|
Tamoxifen for early breast cancer: an overview of the randomised ...
BACKGROUND: There have been many randomised trials of adjuvant tamoxifen among women with early breast cancer, and an updated overview of their results is ...
http://www.ncbi.nlm.nih.gov/pubmed/9605801...
|
Clinical Alert: Adjuvant Therapy of Breast Cancer - Tamoxifen Update
The National Cancer Institute wants to bring new information regarding the optimal duration of adjuvant tamoxifen therapy to the attention of clinicians. ...
http://www.nlm.nih.gov/databases/alerts/tamoxifen.html...
|
Tamoxifen for prevention of breast cancer: report of the National ...
BACKGROUND: The finding of a decrease in contralateral breast cancer incidence following tamoxifen administration for adjuvant therapy led to the concept ...
http://www.ncbi.nlm.nih.gov/pubmed/9747868...
|
Newer Drug Beats Tamoxifen for Older Breast Cancer Patients ...
20 Aug 2009 ... Both letrozole and tamoxifen have been used to prevent ... The new study compared the impact of the newer drug, letrozole, to tamoxifen. ...
http://www.nlm.nih.gov/medlineplus/news/fullstory_88337.html...
|
Initial Results of the Study of Tamoxifen and Raloxifene (STAR ...
17 Apr 2006 ... Uterine cancers, especially endometrial cancers, are a rare but serious side effect of tamoxifen. Both tamoxifen and raloxifene are known to ...
http://www.nih.gov/news/pr/apr2006/nci-17.htm...
|
Anastrozole alone or in combination with tamoxifen versus ...
BACKGROUND: In the adjuvant setting, tamoxifen is the established treatment for postmenopausal women with hormone-sensitive breast cancer. ...
http://www.ncbi.nlm.nih.gov/pubmed/12090977...
|
Gene Test Might Predict Tamoxifen's Effectiveness: MedlinePlus
7 Oct 2009 ... TUESDAY, Oct. 6 (HealthDay News) -- A genetic variant seems to predict resistance to the breast cancer drug tamoxifen, German researchers ...
http://www.nlm.nih.gov/medlineplus/news/fullstory_90262.html...
|
Tamoxifen for the prevention of breast cancer: current status of ...
BACKGROUND: Initial findings from the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial (P-1) demonstrated that tamoxifen ...
http://www.ncbi.nlm.nih.gov/pubmed/16288118...
|
|